As more U.S. states legalize recreational cannabis and public interest continues to gain momentum, cannabidiol (CBDs) are seeing their popularity surge. Unlike tetrahydrocannabinol (THC), CBDs do not get consumers “high” or impair them as stereotypically associated with marijuana. This allows consumers to benefit from the medicinal properties of cannabis, without getting “high” or dealing with effects of THC. In addition, hemp CBD oil is sold in all 50 states.
CBDs continue to be studied all over the world in order to learn their true medicinal value. However, many people have credited CBDs with easing the symptoms of some major ailments: Arthritis, diabetes, alcoholism, chronic pain, inflammation, MS, depression, anxiety, schizophrenia, PTSD, epilepsy, and more. However, more clinical testing and trials are needed to fully confirm what CBDs can treat.
According to market research firm, Brightfield Group, the hemp CBD market will be worth $1 billion by 2020. This represents an annual compound growth rate (CAGR) of 55% between 2017-2020. Brightfield Group attributes much of this growth to the fact that hemp-based CBDs remain legal in all 50 states and have remained “under the radar” of the regulatory issues surrounding the overall cannabis industry.
One company that stands to benefit from the massive growth outlook in CBDs is Canbiola, Inc. (OTC Pink: CANB).
Canbiola, Inc. (OTC Pink: CANB) is engaged within the sale and distribution of a wide range of cannabidiol consumer products: oils, creams, lotions, moisturizers, vapes, chews, isolates, gel caps, concentrates, and water. The company’s mission is to provide the highest quality and purity hemp CBD products at the lowest prices.
Canbiola (CANB) Logo
The company stands apart from other CBD producers in that it utilizes state-of-the-art nanotechnology to break down the CBD molecule sizes to 30-60 nanometers, using ultrasonic sound waves. This process allows for high bioavailability of active ingredients.
Unlike some CBD producers, Canbiola, Inc. (OTC Pink: CANB) uses pure ingredients that are organic or natural. The company lab tests all of its products through Dragon Analytical Labs to ensure that everything meets their high-quality standards. The company is currently developing its own proprietary line of CBD products and will continue to search for synergistic value through acquisitions in the hemp industry.
Aside from cannabis, Canbiola, Inc. (OTC Pink: CANB) also own two technology services:
To View and Purchase Canbiola Products: Click Here
1/3/18 – The company provided an update to shareholders on the year-end review of 2017, which showed major accomplishments. Canbiola, Inc. (OTC Pink: CANB) successfully transitioned from a technology & software company to a cannabis-focused business with growing sales.
Five medical professionals were appointed to the company’s Medical Advisory Board, with four signing on to be distributors:
– Dr. Robert A. Kornfeld: Medical Advisor and Distributor
– Dr. John P. Salerno: Medical Advisor and Distributor
– Dr. Patrick M. Fratellone: Medical Advisor and Distributor
– Dr. Harry Benisatto: Medical Advisor and Distributor
– Dr. Smita Ohri (M.D.): Medical Advisor
Canbiola, Inc. (OTC Pink: CANB) established a manufacturing agreement with a 3rd party manufacturer during the third quarter 2017. This will allow the company to directly manufacture its products (at manufacturers’ cost) and white-label other product with no worry of up-front fees.
“This step makes us self-sufficient so that we no longer must rely on outside manufacturers, while greatly improving our operating margins from the reduced costs associated with the new agreement. The company has also acquired a 10-year option to purchase the manufacturing facility from the 3rd party manufacturer.”
1/16/18 – Canbiola, Inc. (OTC Pink: CANB) announces a strategic partnership with Grey Cloak Tech, Inc. (OTCQB: GRCK) to list its line of CBD products on GRCK’s new marketplace, CBD.co.
“We’re pleased to be doing a Joint Venture with CBD.co, for the simple reason CBD.Co does the rigorous vetting of all of the products that reside on their site, that’s a creating incredible Marketplace for CBD vendors that qualify. It’s important to have our two companies work together to create a marketplace that’s amenable to everybody’s thought process moving forward because at the end of the day it’s all about sales. If you can’t sell a product and can’t get the word out there, you get stifled,” detailed Canbiola, Inc. (OTC Pink: CANB) CEO, Marco Alfonsi.
1/29/18 – Canbiola, Inc. (OTC Pink: CANB) announces that it has streamlined its supply chain by cutting out the middle-man and the added manufacturing fees. As a result of the changes, the company is passing the savings onto the customer by reducing product prices by nearly 30% across the board.
”Our products benefit our clients with a variety of health issues, naturally, but the industry cost is high and reducing our overall production costs allows us to decrease our retail prices to customers and increase our market share. Canbiola is committed to bringing the highest quality products in the most cost-effective way to its customers, something we believe is beneficial to all. Our customers will get more for their hard-earned money and the company should benefit through solid growth in revenues and profit because of these new hypercompetitive prices,” details Mr. Alfonsi.
Canbiola, Inc. (OTC Pink: CANB) has a market cap of $6.65 million, as of January 2018. Furthermore, the CBD products developer maintains a share structure consisting of 750 million authorized shares, 225.57 million outstanding shares, and a float of 50.94 million shares. During the third quarter 2017, Canbiola, Inc. (OTC Pink: CANB) reported $22,000 in total revenue and net income of $18,000.
However, according to a recent press release from the company: “We will report our 4th Quarter and full year (2017) results of operations in our 2017 annual report, but can announce today that product sales (unaudited) for the 4th quarter exceeded the combined product sales (unaudited) for the 3 preceding quarters of 2017.”
Source: OTC Markets
After successfully completing the transition from technology & software to the cannabis industry in 2017, Canbiola, Inc. (OTC Pink: CANB) is preparing for a strong 2018. The company experienced strong sales growth in its premium CBD products during the last three months of 2017, which highlights further potential in sales growth for this year. Canbiola, Inc. (OTC Pink: CANB) has been busy expanding partnerships and growing the company’s medical advisor board, which will help continue to ensure product quality and greater distribution reach. While Canbiola, Inc. (OTC Pink: CANB) is a newcomer to the massive CBD market, the company’s unique approach and medicinal-grade product is already a formidable challenger to the “status quo” of uneven product quality across a large part of the CBD industry. Here are five other CBD companies that could help determine a proper fair valuation for Canbiola, Inc. (OTC Pink: CBD):
Puration, Inc. (OTC Pink: PURA): After starting out as a water purification company, the company has quickly shifted its focus to the cannabis market in the past several months. Puration, along with partners North American Cannabis Holdings, Inc. (OTC Pink: USMJ), are focused on developing and launching new CBD-infused sports drink called EVERx. Puration has also announced plans to expand its holdings further throughout the cannabis market. As of January 2018, Puration has a market cap of $13.6 million. Furthermore, the company has a market structure consisting of 500 million authorized shares, 388.47 million shares outstanding, and a float of 277.58 million shares, as of October 2017. During third quarter 2017, combined water purification and cannabis operations generated total revenue of $168,000 and a net loss of $124,000.
HempAmericana, Inc. (OTC Pink: HMPQ): The company operates within the research, development, and sale of products derived from industrial hemp. One of the company’s primarily consumer products are CBD oils and “Rolling Thunders,” hemp-based rolling papers. HempAmericana recently announced that it will begin CBD oil production by the end of January 2018, as the company prepares to take delivery of Supercritical CO2 Extractor Machine. As of January 2018, HempAmericana has a market cap value of $42.97 million. Furthermore, the industrial hemp company maintains a share structure consisting of 6 billion shares authorized and 1.38 billion shares outstanding. During the company’s latest fiscal quarter ending on November 11, 2017, HempAmericana reported no revenues and a net loss of $296,440.
Marijuana Company of America, Inc. (OTC Pink: MCOA): The cannabis company has a more diversified approach to the market. Marijuana Company of America develops CBD consumer products through its “hempSMART” brand, which promotes general health and wellness. The company also leases out real estate property to cannabis companies within areas where marijuana is legal medicinally or recreationally. Over time, the company is interested in expanding into other ancillary areas of the cannabis and hemp markets. As of January 2018, Marijuana Company of America has a market cap of $85.96 million. Furthermore, the company operates a share structure consisting of 5 billion authorized shares, 2.07 billion outstanding shares, and a float of 579.17 million shares, as of November 2017. During the third quarter 2017, the company reported total revenue of $2,000 and a net loss of $3.88 million.
Potnetwork Holdings, Inc. (OTC Pink: POTN): The holding company’s one subsidiary, First Capital Venture Co., is the owner of Diamond CBD. Diamond CBD delivers a premium hemp extract that “contains a broad range of cannabinoids and natural hemp derivatives.” The company strives to produce one of the most powerful and natural CBD oil products on the market. Potnetwork Holdings, Inc. has a market cap of $229.43 million, as of January 2018. Furthermore, the company maintains a share structure consisting of 1 billion authorized shares, 269.92 million outstanding shares, and a float of 269.92 million shares, as of November 2017. During the third quarter 2017, Potnetwork Holdings reported total revenue of $4.44 million on net income of $293,000.
Medical Marijuana, Inc. (OTC Pink: MJNA): The industrial hemp and cannabis company focuses on the research, development, sale, and distribution of CBD-rich hemp oils. The company’s CBD oil is formulated and marketed to the pharmaceutical, nutraceutical, and cosmeceutical industries. Medical Marijuana, Inc. has a market cap of $354.54 million, as of January 2018. Furthermore, the CBD oil company maintains a share structure consisting of 5 billion authorized shares, 3.18 billion outstanding shares, and a float of 411.05 million shares, as of June 2017. During the third quarter 2017, Medical Marijuana, Inc. reported total revenue of $7.78 million and a net loss of $2.96 million.
Overall, Canbiola, Inc. (OTC Pink: CANB) is extremely undervalued relative to some of its peers. HempAmericana, Inc. sports a market cap of just under $43 million, yet the company has no revenues or sales growth to back up its lofty valuation. Their bloated market cap is likely due to speculation over future operations and a chance to start generating revenues. Marijuana Company of America, Inc. is an even larger example of how undervalued Canbiola, Inc. (OTC Pink: CANB) could be: MCOA has market cap of nearly $86 million, yet they are hemorrhaging cash on a massive scale as the $3.88 million loss in the third quarter shows. Some CBD and cannabis companies have achieved massive valuations due to speculation and reliance on forward-looking statements. Meanwhile, Canbiola, Inc. (OTC Pink: CANB) is reporting actual information on strong sales and revenue growth, yet trades at a massive discount to its peers. Canbiola, Inc. (OTC Pink: CANB) is positioned for a major breakout year in 2018.
Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.
All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated five hundred dollars cash for the creation and dissemination of this content.
This material does not represent an investment solicitation. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.
The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: http://spotlightgrowth.com/index.php/disclosures/